Read this prospect carefully before starting to take this medicine, because it contains important information for you.
-Keep this prospect, as you may need to read it again.
- If you have any doubts, consult your doctor or pharmacist.
- This medicine has been prescribed only to you, and you must not give it to other people even if they have the same symptoms as you, as it may harm them.
- If you experience any adverse effects, consult your doctor or pharmacist, even if they are not listed in this prospect. See section 4.
Pregabalina belongs to a group of medications used for the treatment of epilepsy, peripheral and central neuropathic pain, and generalized anxiety disorder (GAD) in adults.
Peripheral and central neuropathic pain:Pregabalina is used for the treatment of chronic pain caused by nerve damage. Various diseases can cause peripheral neuropathic pain, such as diabetes or herpes. The pain sensation could be described as heat, burning, pulsating pain, stabbing pain, acute pain, spasms, continuous pain, tingling, numbness, and pins and needles sensation. Peripheral and central neuropathic pain could also be associated with mood changes, sleep disturbances, fatigue (tiredness), and may affect physical and social activity and overall quality of life.
Epilepsy:Pregabalina is used in the treatment of certain types of epilepsy (partial seizures with or without secondary generalization) in adults. Your doctor will prescribe pregabalina to treat epilepsy when your current treatment does not control the disease. You must take pregabalina in addition to your current treatment. Pregabalina should not be administered alone, but always used in combination with other antiepileptic treatments.
Generalized anxiety disorder:Pregabalina is used in the treatment of generalized anxiety disorder (GAD). Symptoms of GAD include excessive and prolonged anxiety and worry that are difficult to control. GAD can also produce restlessness or feeling of excitement or nervousness, feeling easily fatigued (tired), difficulty concentrating or feeling mentally blank, irritability, muscle tension, or sleep disturbances. This is different from everyday life stress and tensions.
Do not take Pregabalina Qualigen
If you are allergic to pregabalin or any of the other ingredients of this medication (listed in section 6).
Warnings and precautions
Consult your doctor or pharmacist before starting to take pregabalin.
·Some patients treated with pregabalin have reported symptoms that suggest an allergic reaction. These symptoms include swelling of the face, lips, tongue, and throat, as well as widespread skin rash. If you experience any of these symptoms, you should seek immediate medical attention.
·Severe skin reactions, such as Stevens-Johnson syndrome and toxic epidermal necrolysis, have been associated with pregabalin treatment. Stop taking pregabalin and seek medical attention immediately if you observe any symptoms related to these severe skin reactions described in section 4.
·It has been associated with dizziness and somnolence, which could increase the risk of accidental injuries (falls) in elderly patients. Therefore, you should be cautious until you become familiar with the effects the medication can have.
·Pregabalin may cause blurred vision, loss of vision, or other changes in vision, many of which are transient. If you experience any alteration in your vision, you should inform your doctor immediately.
·Patients with diabetes who gain weight while taking pregabalin may need to change their diabetes medications.
·Certain adverse effects, such as somnolence, may be more frequent since patients with spinal cord injury may be taking other medications for treatment, for example, pain or spasticity (tense or rigid muscles), with adverse effects similar to those of Pregabalina, so the intensity of these effects may increase when taken together.
·Severe cases of heart failure have been reported in some patients treated with this medication. Most of them were elderly patients with cardiovascular diseases.Before using this medication, you must inform your doctor if you have a history of heart disease.
·Severe cases of kidney failure have been reported in some patients treated with this medication. If during treatment with pregabalin you notice a decrease in your ability to urinate, you should inform your doctor as the interruption of treatment may improve this situation.
·Some patients treated with antiepileptic drugs, such as pregabalin, have had thoughts of self-harm or suicide or have shown suicidal behavior. If at any time you experience these thoughts or have shown such behavior, contact your doctor as soon as possible.
·When pregabalin is taken with other medications that can cause constipation (such as some types of pain medications), it is possible that gastrointestinal problems (e.g., constipation and intestinal blockage or paralysis) may occur. Inform your doctor if you experience constipation, especially if you are prone to this problem.
·Before taking this medication, inform your doctor if you have ever abused or have had dependence on alcohol, prescription medications, or illegal drugs; it may mean that you have a higher risk of becoming dependent on pregabalin.
·Severe cases of seizures have been reported during treatment with pregabalin or shortly after stopping treatment with this medication. If you experience seizures, contact your doctor immediately.
·Severe cases of encephalopathy (brain dysfunction) have been reported in some patients who were taking pregabalin and had other serious diseases. Inform your doctor if you have a history of any serious disease, including liver or kidney disease.
·Severe cases of respiratory difficulty have been reported. If you have nervous system disorders, respiratory disorders, kidney failure, or are over 65 years old, your doctor may prescribe a different dose. Contact your doctor if you experience breathing problems or shallow breathing.
Dependence
Some people may become dependent on pregabalin (need to continue taking the medication). They may experience withdrawal effects when they stop using pregabalin (see section 3, "How to take Pregabalina Qualigen" and "If you stop taking Pregabalina Qualigen"). If you are concerned that you may become dependent on pregabalin, it is essential to consult your doctor.
If you notice any of the following signs while taking pregabalin, it could be a sign that you have become dependent:
If you notice any of these signs, talk to your doctor to analyze the best plan of care for you, including when it is appropriate to stop treatment and how to do it safely.
Children and adolescents
The safety and efficacy have not been established in children and adolescents (under 18 years) so pregabalin should not be used in this age group.
Other medications and Pregabalina Qualigen
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Pregabalin and certain medications may exert a mutual influence on each other (interactions). When pregabalin is used with certain medications that have a sedative effect (including opioids), these effects may be potentiated, and may lead to respiratory failure, coma, and death. The degree of dizziness, somnolence, and decreased concentration may increase if pregabalin is taken with other medications that contain:
Oxycodone – (used as an analgesic)
Lorazepam – (used to treat anxiety)
Alcohol
Pregabalin can be taken with oral contraceptives.
Taking Pregabalina Qualigen with food, drinks, and alcohol
Pregabalin capsules can be taken with or without food.
It is recommended not to take alcohol during treatment with pregabalin.
Pregnancy, breastfeeding, and fertility
You should not take pregabalin during pregnancy or lactation, unless your doctor has told you to. The use of pregabalin during the first 3 months of pregnancy may cause congenital anomalies in the fetus that require medical treatment. In a study that reviewed data from women in Nordic countries who took pregabalin during the first 3 months of pregnancy, 6 out of 100 babies had such congenital anomalies. This contrasts with 4 out of 100 babies born to women not treated with pregabalin in the study. Congenital anomalies of the face (cleft palate), eyes, nervous system (including the brain), kidneys, and genitals have been reported.
A reliable contraceptive method should be used in women of childbearing age.If you are pregnant or breastfeeding, believe you may be pregnant, or intend to become pregnant, consult your doctor or pharmacist before using this medication.
Driving and operating machinery
Pregabalin may cause dizziness, somnolence, and decreased concentration. You should not drive, operate heavy machinery, or engage in other potentially hazardous activities until you know if this medication affects your ability to perform these activities.
Follow exactly the administration instructions of this medication as indicated by your doctor.
In case of doubt, consult your doctor or pharmacist again. Do not take more medication than prescribed.
Your doctor will determine the appropriate dose for you.
Pregabalina is exclusively for oral use.
Peripheral and central neuropathic pain, epilepsy, or generalized anxiety disorder:
If you estimate that the action of pregabalina is too strong or too weak, inform your doctor or pharmacist.
If you are an elderly patient (over 65 years old), you should take pregabalina normally, except if you have kidney problems.
Your doctor may prescribe a different dosing regimen and/or different doses if you have kidney problems.
Swallow the capsule whole with water.
Continue taking pregabalina until your doctor tells you to stop.
If you take more Pregabalina Qualigen than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
As a result of having taken more pregabalina than you should, you may feel drowsy, confused, agitated, or restless. Seizures and loss of consciousness (coma) have also been reported.
If you forgot to take Pregabalina Qualigen
It is essential to take the pregabalina capsules regularly at the same time every day. If you forget to take a dose, take it as soon as you remember, unless it is time for the next dose. In that case, continue with the next dose normally. Do not take a double dose to compensate for the missed doses.
If you interrupt the treatment with Pregabalina Qualigen
Do not stop taking pregabalina suddenly. If you want to stop taking pregabalina, talk to your doctor first. He will tell you how to do it. If you are going to stop treatment, this should be done gradually over a minimum of one week.
Once a short- or long-term treatment with pregabalina is completed, you should know that you may experience certain adverse effects, called withdrawal effects. These effects include insomnia, headaches, nausea, anxiety, diarrhea, flu-like symptoms, seizures, nervousness, depression, thoughts of self-harm or suicide, pain, sweating, and dizziness. These effects may appear more frequently or severely if you have been taking pregabalina for a longer period. If you experience withdrawal effects, consult your doctor.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
The very common side effects that may affect more than 1 in 10 people are:
·Dizziness, somnolence, headache
The common side effects that may affect more than 1 in 100 people are:
·Increased appetite
·Euphoria, confusion, disorientation, decreased sexual appetite, irritability
·Attention disturbance, clumsiness of movement, deterioration of memory, loss of memory, tremors, difficulty speaking, sensation of paresthesia, numbness, sedation, lethargy, insomnia, fatigue, abnormal sensation
·Blurred vision, double vision
·Dizziness, balance problems, falls
·Dry mouth, constipation, vomiting, flatulence, diarrhea, nausea, swollen abdomen
·Difficulty in erection
·Swelling of the body including extremities
·Sensation of intoxication, alterations in gait
·Weight gain
·Muscle cramps, pain in joints, back pain, pain in extremities
·Throat pain
The uncommon side effects that may affect more than 1 in 1,000 people are:
·Loss of appetite, weight loss, low blood sugar, high blood sugar
·Change in perception of self, restlessness, depression, agitation, mood changes, difficulty finding words, hallucinations, strange dreams, anxiety crises, apathy, aggression, elevated mood, mental deterioration, difficulty thinking, increased sexual appetite,sexual dysfunction including inability to achieve orgasm, delayed ejaculation.
·Changes in vision, abnormal eye movements, changes in vision including tunnel vision, flashes of light, spasmodic movements, decreased reflexes, hyperactivity, dizziness on standing, sensitive skin, loss of taste, burning sensation, tremors on movement, decreased consciousness, loss of consciousness, fainting, increased sensitivity to sounds, general discomfort.
·Eye dryness, eye swelling, eye pain, tired eyes, watery eyes, eye irritation.
·Alterations in heart rhythm, increased heart rate, low blood pressure, high blood pressure, changes in heart rhythm, heart failure.
·Rubor, hot flashes.
·Difficulty breathing, dry nose, nasal congestion.
·Increased saliva production, burning sensations, numbness around the mouth.
·Sweating, rashes, chills, fever.
·Muscle spasms, joint swelling, muscle rigidity, pain including muscle pain, neck pain.
·Breast pain.
·Difficulty or pain urinating, inability to hold urine.
·Weakness, thirst, chest oppression.
·Changes in blood and liver test results (elevated creatine phosphokinase in blood, elevated alanine aminotransferase, elevated aspartate aminotransferase, decreased platelet count, neutropenia, elevated creatinine in blood, decreased potassium in blood).
·Hypersensitivity, facial swelling, itching, urticaria, runny nose, nasal bleeding, cough, snoring.
·Menstrual cramps.
·Sensation of cold in hands and feet.
The rare side effects that may affect less than 1 in 10,000 people are:
·Altered sense of smell, oscillating vision, altered perception of depth, visual brightness, loss of vision
·Dilated pupils, strabismus
·Cold sweat, throat oppression, tongue swelling
·Pancreatitis
·Difficulty swallowing
·Slow or reduced body movement
·Difficulty writing correctly
·Increased fluid in the abdominal area
·Pulmonary edema
·Convulsions
·Changes in electrocardiogram (ECG) corresponding to alterations in heart rhythm
·Muscle damage
·Milk secretion, abnormal breast growth, increased breast size in men
·Menstrual period interruption
·Renal insufficiency, decreased urine output, urinary retention
·Decreased white blood cell count
·Inappropriate behavior, suicidal behavior, suicidal thoughts
·Severe skin reactions that may include difficulty breathing, eye inflammation (keratitis), and a severe skin reaction characterized by flat, red patches, often with central blisters, desquamation of the skin, ulcers in the mouth, throat, nose, genitals, and eyes. These severe skin reactions may be preceded by fever and flu-like symptoms (Stevens-Johnson syndrome, toxic epidermal necrolysis)
·Ictericia (yellow skin and eyes)
·Parkinsonism, Parkinson's disease-like symptoms, such as tremors, bradykinesia (decreased ability to move), and muscle rigidity.
The very rare side effects that may affect up to 1 in 10,000 people are:
· Hepatic insufficiency.
· Hepatitis (inflammation of the liver).
The side effects of unknown frequency that cannot be estimated from available data are:
· Dependence on pregabalin (“drug dependence”).
Once a short- or long-term treatment with pregabalin is completed, you should know that you may experience certain side effects, called withdrawal effects (see “If you stop taking Pregabalin Qualigen”).
If you experience swelling in the face or tongue, or if your skin becomes red and blistered or peels, you should seek immediate medical attention.
Certain side effects, such as drowsiness, may be more frequent since patients with spinal cord injury may be taking other medications to treat, for example, pain or spasticity (stiff or rigid muscles), with side effects similar to those of pregabalin, so the intensity of these side effects may increase when taken together.
There have been reports of the following adverse reaction in the postmarketing experience: difficulty breathing, shallow breathing.
Reporting of adverse reactions
If you experience any type of adverse reaction, consult your doctor or pharmacist, even if it is a possible adverse reaction that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es.
By reporting adverse reactions, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after the abbreviation CAD.The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through drains or trash. Dispose of the packaging and medications you no longer need at the SIGRE collection pointat the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Pregabalina Qualigen Composition
The active ingredient is pregabalin. Each hard capsule contains 25 mg of pregabalin.
The other components (excipients) are: mannitol (E-421), pregelatinized cornstarch, talc, titanium dioxide (E-171), yellow iron oxide (E-172), and gelatin.
The printing ink components are: shellac lacquer, black iron oxide (E-172), propylene glycol, strong ammonia solution, and potassium hydroxide.
Appearance of the product and contents of the pack
Pregabalina Qualigen 25 mg are hard, opaque, ivory-colored gelatin capsules with "25" engraved.
Blister packsofPVC/Aluminumincartonscontaining56hardcapsules.
Pre-cutunit-dosePVC/Aluminumblister packsincartonscontaining56hardcapsules.
Possibleonlysomepacksizesmaybemarketed.
Marketing Authorization Holder and Responsible Person for Manufacturing
Marketing Authorization Holder
Neuraxpharm Spain, S.L.U.
Avda. Barcelona, 69
08970 Sant Joan Despí
Barcelona - Spain
Responsible Person for Manufacturing
Pliva Croatia, Ltd.
Prilaz Baruna Filipovica 25
10000 Zagreb
Croatia
or
Merckle GmbH
Ludwig-Merckle Strasse 3
D-89143 Blaubeuren - Weiler
Germany
Last review date of this leaflet:December 2023
The detailed information of this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.